Re: Atypical

From: Elrod, Darryl G Maj 48 MDOS/SGOBO (Darryl.elrod@LAKENHEATH.AF.MIL)
Wed Mar 28 08:14:40 2007


If I do a hyst and she has a well diff uterine cancer, she would then need to be staged, correct?

Would the TVH/TAH adversely affect her overall outcome if that were the case?

Glen

//SIGNED//

D. Glen Elrod, Maj., USAF, MC

Obstetrician/Gynecologist

Chief of Obstetrics

48 MDOS/SGOBO

RAF Lakenheath, England

Telephone DSN: 314-226-8130

Comm: +44 (0) 1638 52 8130

Notice of Confidentiality Under the Privacy Act of 1974, you must safeguard all information reflected on this e-mail and, if applicable, all attachments. Disclosure of information is IAW AFI 33-119, AFI 33-127, AFI 37-131, AFI 37-132, AFI 33-219, and PL 93-579" This e-mail message including any attachments is for the sole use of the intended recipient(s) and may contain confidential and privileged information. Any unauthorized review, use, disclosure or distribution is prohibited. If you are not the intended recipient, please contact the sender by reply e-mail and destroy all copies of the original message. Any questions pertaining to disclosure should be directed to the privacy officer.

-----Original Message----- From: ob-gyn-l@obgyn.net [mailto:ob-gyn-l@obgyn.net] On Behalf Of Dr. John Provatopoulos B.Sc. M.D.C.M. F.R.S.C. Sent: Wednesday, March 28, 2007 12:54 PM To: Multiple recipients of list OB-GYN-L Subject: Re: Atypical

At Wed, 28 Mar 2007, Elrod, Darryl G Maj 48 MDOS/SGOBO wrote: >
>69 yo G2P2 with postmenopausal bleeding, not entirely known where the
>source was at first. Had a colonoscopy and cystoscopy prior to getting
>to me.
>
>EMB shows atypical glandular proliferation, no hyperplasia seen.
>
>Suggestions for treatment? The patient is not keen on medication or
>further biopsies and wants definitive treatment.
>
>Thanks,
>
>Glen
>
>//SIGNED//
>
>D. Glen Elrod, Maj., USAF, MC
>
>Obstetrician/Gynecologist
>
>Chief of Obstetrics
>
>48 MDOS/SGOBO
>
>RAF Lakenheath, England
>
>Telephone DSN: 314-226-8130
>
> Comm: +44 (0) 1638 52 8130
>
>Notice of Confidentiality
>Under the Privacy Act of 1974, you must safeguard all information
>reflected on this e-mail and, if applicable, all attachments.
>Disclosure of information is IAW AFI 33-119, AFI 33-127, AFI 37-131,
AFI >37-132, AFI 33-219, and PL 93-579"
>This e-mail message including any attachments is for the sole use of
the >intended recipient(s) and may contain confidential and privileged
>information. Any unauthorized review, use, disclosure or distribution
is >prohibited. If you are not the intended recipient, please contact the
>sender by reply e-mail and destroy all copies of the original message.
>Any questions pertaining to disclosure should be directed to the
privacy >officer.

Vag hsyt BSO, TAH BSO depending on anatomy etc. 20-50% chance they see well diff adeno on final pathalogy.

--
                                 Take care, John




use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Fri May 2 04:47:14 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.